Smith Nephew Ownership
| SNNUF Stock | USD 14.00 0.86 6.54% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Smith |
Smith Pink Sheet Ownership Analysis
About 53.0% of the company shares are owned by institutional investors. The book value of Smith Nephew was at this time reported as 6.16. The company has Price/Earnings To Growth (PEG) ratio of 1.06. Smith Nephew plc last dividend was issued on the 29th of September 2022. Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 18000 people.The quote for Smith Nephew plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Smith Nephew plc contact Deepak Nath at 44 1923 477 100 or learn more at https://www.smith-nephew.com.Currently Active Assets on Macroaxis
Other Information on Investing in Smith Pink Sheet
Smith Nephew financial ratios help investors to determine whether Smith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.